Mikel Berdud : Citation Profile


Office of Health Economics

2

H index

0

i10 index

12

Citations

RESEARCH PRODUCTION:

2

Articles

8

Papers

RESEARCH ACTIVITY:

   10 years (2012 - 2022). See details.
   Cites by year: 1
   Journals where Mikel Berdud has often published
   Relations with other researchers
   Recent citing documents: 2.    Total self citations: 1 (7.69 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pbe1130
   Updated: 2025-12-27    RAS profile: 2022-09-20    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Mikel Berdud.

Is cited by:

Husereau, Don (1)

Blankart, Katharina (1)

Han, Euna (1)

Kemp, Ron (1)

Cites to:

Tirole, Jean (14)

Jewitt, Ian (10)

Dewatripont, Mathias (10)

Hwang, Sung-Ha (6)

Ghatak, Maitreesh (6)

Mueller, Hannes (4)

Delfgaauw, Josse (3)

Dur, Robert (3)

Dixit, Avinash (3)

Frey, Bruno (3)

Sen, Amartya (2)

Main data


Where Mikel Berdud has published?


Working Papers Series with more than one paper published# docs
Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra / Departamento de Economía - Universidad Pública de Navarra6

Recent works citing Mikel Berdud (2025 and 2024)


YearTitle of citing document
2024The impact of an ‘evergreening’ strategy nearing patent expiration on the uptake of biosimilars and public healthcare costs: a case study on the introduction of a second administration form of trastuzumab in The Netherlands. (2024). Kemp, Ron ; Makai, Peter ; Timmers, Lonneke ; Kirshner, Ghyli ; Brouns, Chiara. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:25:y:2024:i:7:d:10.1007_s10198-023-01648-w.

Full description at Econpapers || Download paper

2025Drug pricing models, no ‘one-size-fits-all’ approach: a systematic review and critical evaluation of pricing models in an evolving pharmaceutical landscape. (2025). Manders, Evert A ; den Berg, Sibren ; Visser, Saco J. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:26:y:2025:i:4:d:10.1007_s10198-024-01731-w.

Full description at Econpapers || Download paper

Works by Mikel Berdud:


YearTitleTypeCited
2019The Future of Global Health Procurement: Issues around Pricing Transparency In: Working Papers.
[Full Text][Citation analysis]
paper3
2022Alternative funding models for medical innovation: the role of product development partnerships in product innovation for infectious diseases In: Post-Print.
[Citation analysis]
paper0
2012Incentives Beyond the Money and Motivational Capital in Health Care Organizations. In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
paper0
2012Motivational Capital and Incentives in Health Care Organisations. In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
paper0
2014Motivational Capital and Incentives in Health Care Organizations.(2014) In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0
paper
2014Motivational Capital and Incentives in Health Care Organizations.(2014) In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0
paper
2012Incentives Beyond the Money: Identity and Motivational Capital in Public Organizations In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
paper0
2014A Pilot Inquiry on Incentives and Intrinsic Motivation in Health Care: the Motivational Capital Explained by Doctors In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
paper0
2016Fostering incentives for research, development, and delivery of interventions for neglected tropical diseases: lessons from malaria In: Oxford Review of Economic Policy.
[Full Text][Citation analysis]
article0
2016Biosimilars: How Can Payers Get Long-Term Savings? In: PharmacoEconomics.
[Full Text][Citation analysis]
article9

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated December, 22 2025. Contact: CitEc Team